Finance

Lists
301331:SHE
Enwei Pharmaceutical Co Ltd
22,12 CN¥
-0,36%
(-0,080) 1D
9-окт., 15:04:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301331...
Open
22,03 CN¥
High
22,32 CN¥
Low
21,35 CN¥
Mkt. cap
2,28 млд
Avg. vol.
1,39 млн
Volume
1,32 млн
Dividend
4,66%
Quarterly dividend
0,26 CN¥
Ex-dividend date
2026-ж., 28-май
P/E ratio
80,59
52-wk high
33,50 CN¥
52-wk low
18,87 CN¥
EPS
0,27 CN¥
Shares outstanding
102,89 млн
No. of employees
2 миң
Open
22,03 CN¥
High
22,32 CN¥
Low
21,35 CN¥
Mkt. cap
2,28 млд
Avg. vol.
1,39 млн
Volume
1,32 млн
Dividend
4,66%
Quarterly dividend
0,26 CN¥
Ex-dividend date
2026-ж., 28-май
P/E ratio
80,59
52-wk high
33,50 CN¥
52-wk low
18,87 CN¥
EPS
0,27 CN¥
Shares outstanding
102,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
About Enwei Pharmaceutical Co Ltd
CEO-
Employees1,5 миң
Founded1986
Headquarters-
SectorPharmaceutical industry
Websiteenwei.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
187,63 млн
263,92 млн
175,33 млн
199,25 млн
Cost of goods sold
102,65 млн
123,62 млн
77,69 млн
105,31 млн
Cost of revenue
102,65 млн
123,62 млн
77,69 млн
105,31 млн
Research and development expenses
1,76 млн
1,22 млн
1,11 млн
1,26 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91,00 млн
108,50 млн
82,73 млн
90,38 млн
Operating expense
93,18 млн
115,42 млн
85,17 млн
93,84 млн
Total operating expenses
195,83 млн
239,04 млн
162,86 млн
199,15 млн
Operating income
-8,20 млн
24,87 млн
12,47 млн
102,77 миң
Other non operating income
341,20 миң
-843,50 миң
-62,65 миң
-245,26 миң
EBT including unusual items
-2,54 млн
20,98 млн
13,88 млн
4,07 млн
EBT excluding unusual items
-6,27 млн
25,60 млн
13,52 млн
248,11 миң
Income tax expense
-782,36 миң
5,62 млн
1,38 млн
553,50 миң
Effective tax rate
30,78%
26,77%
9,93%
13,59%
Other operating expenses
2,36 млн
3,57 млн
1,89 млн
2,41 млн
Net income
-1,76 млн
15,36 млн
12,50 млн
3,52 млн
Net profit margin
-0,94%
5,82%
7,13%
1,77%
Earnings per share
-
-
-
-
Interest and investment income
2,19 млн
1,88 млн
1,69 млн
892,61 миң
Interest expense
-606,94 миң
-308,97 миң
-578,12 миң
-502,01 миң
Net interest expenses
1,59 млн
1,57 млн
1,11 млн
390,60 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
3,02 млн
36,41 млн
24,01 млн
12,01 млн
Gain or loss from assets sale
-263,27 миң
138,01 миң
-
-2,69 млн
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору